EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Global prevalence of metabolic syndrome in patients with gout: A systematic review and meta-analysis

Pegah Heidarian, Amir Jalali iD, Ali Shirzadi, Romina Jalali, Ebrahim Ezzati

Nutrition and Health · 2025

DOI: 10.1177/02601060251323013 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nutrition and Health, 2025. Verfasst von Pegah Heidarian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Global Health, Gout, Metabolic Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence increasingly supports the association of gout with metabolic syndrome (MetS). Studies have indicated that the prevalence of MetS among patients with gout ranges from 17 to over 70 percent.

Aim

The purpose of this study was to establish the global prevalence of MetS in patients diagnosed with gout.

Methods

To obtain studies related to the title, we systematically searched PubMed, Scopus, Web of Science, Embase, Science-Direct, and Google Scholar search engine to find all relevant articles that were published until the end of November 2023. Obtain and carry out the necessary evaluations. The I 2 index was used to examine the heterogeneity of studies and the Random Effects model was used to analyze the data.

Results

Following evaluation, we discovered 19 studies (23 findings), revealing an overall prevalence of MetS in gout patients as 46.8% (95% CI: 38.6–55.2%). On a regional level, subgroup analysis indicated the highest prevalence of MetS was in the American continent, with a rate of 60.6% (95% CI: 44.8–74.5%). In terms of the tool used for MetS measurement, the subgroup analysis showed the maximum prevalence rate of 54.6% was associated with the International Diabetes Federation criteria tool.

Conclusion

The results of this research showed that MetS is common among gout patients; therefore, policymakers should reduce the consequences and costs of this condition by focusing on these patients and performing appropriate and timely treatment and training.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Global HealthGoutMetabolic SyndromeFemaleHumansMaleMiddle AgedPrevalence

Stichwörter der Autor:innen

MetSPrevalencegoutmeta-analysismetabolic syndrome

Autor:innen und Institutionen

  • Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Substance Abuse Prevention Research Center, Research Institute for Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Sleep Disorder Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Anaesthesiology, School of paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran.

ORCID-Profile: Amir Jalali

Zitieren

APA

Heidarian, P., Jalali, A., Shirzadi, A., Jalali, R., & Ezzati, E. (2025). Global prevalence of metabolic syndrome in patients with gout: A systematic review and meta-analysis. Nutrition and Health. https://doi.org/10.1177/02601060251323013

Vancouver

Heidarian P, Jalali A, Shirzadi A, Jalali R, Ezzati E. Global prevalence of metabolic syndrome in patients with gout: A systematic review and meta-analysis. Nutrition and Health. 2025. doi:10.1177/02601060251323013

BibTeX
@article{Heidarian2025,
  author = {Heidarian, Pegah and Jalali, Amir and Shirzadi, Ali and Jalali, Romina and Ezzati, Ebrahim},
  title = {Global prevalence of metabolic syndrome in patients with gout: A systematic review and meta-analysis},
  journal = {Nutrition and Health},
  year = {2025},
  doi = {10.1177/02601060251323013}
}
Kostenlos starten →